-
ANALYSIS OF HOSPITAL LENGTH OF STAY IN HONG KONG: EFFECTS OF AGE, CONDITIONS, AND COMORBIDITY INTERACTIONS
Mar 18, 2026, 21:38 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED EXTRAPOLATIONS OF TIME-TO-EVENT OUTCOMES IN MULTISTATE MODELS
Mar 18, 2026, 21:38 PM -
ALIGNING PATIENTS ACROSS ARMS: WHY COMMON RANDOM NUMBERS IMPROVE EFFICIENCY IN PARTITIONED SURVIVAL MODELS
Mar 18, 2026, 21:38 PM -
DETERMINANTS OF DELAY IN EGFR INHIBITOR INITIATION AND ITS IMPACT ON CLINICAL OUTCOMES IN NON-SMALL CELL LUNG CANCER PATIENTS
Mar 18, 2026, 21:38 PM -
IMPACT OF TIME-VARYING RELAPSE RISK ON LONG-TERM COST-EFFECTIVENESS OUTCOMES IN CHRONIC RELAPSING DISEASES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF UBLITUXIMAB FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS
Mar 18, 2026, 21:38 PM -
A SNAPSHOT ASSESSMENT OF THE IMPLEMENTATION OF BROADER VALUE ELEMENTS IN ECONOMIC EVALUATIONS: FROM GUIDANCE TO PRACTICE
Mar 18, 2026, 21:38 PM -
THE SAFETY AND EFFECTIVENESS OF STERILE HYPOCHLOROUS ACID USED AS SURGICAL IRRIGATION SOLUTION TO REDUCE POSTOPERATIVE COMPLICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
EVALUATING VARIABLE-SELECTION STRATEGIES FOR EXTERNAL CONTROL ARM STUDIES: A MONTE CARLO ASSESSMENT OF DIRECTED ACYCLIC GRAPH, PROGNOSTIC RANKING, AND MACHINE-LEARNING APPROACHES
Mar 18, 2026, 21:38 PM -
HOW HAVE ECONOMIC EVALUATIONS EVALUATED UNCERTAINTY IN POLYGENIC RISK SCORES?: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD FUNCTIONAL, ECONOMIC, AND BEHAVIORAL BURDEN OF ACUTE GLUTEN EXPOSURE IN U.S. ADULTS WITH CELIAC DISEASE: INSIGHTS FROM A LARGE NATIONAL COHORT
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF SAVOLITINIB VERSUS GLUMETINIB IN THE FIRST-LINE TREATMENT OF CHINESE ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER HARBORING MET EXON 14 SKIPPING MUTATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD CTDNA TEST UTILIZATION AND ASSOCIATED COSTS IN US PATIENTS WITH BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD IMPACT OF CURRENT TREATMENTS ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN ADULTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ENDOMETRIAL CANCER TREATMENT IN THE PUBLIC SETTING IN BRAZIL
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF ALPHA BLOCKERS VERSUS ALPHA INHIBITORS USING PATIENT-REPORTED OUTCOMES AMONG ADULT MEN DIAGNOSED WITH BPH IN THE USA USING MEPS DATA (2018-2023)
Mar 18, 2026, 21:38 PM -
A HEALTH ECONOMIC AND ENVIRONMENTAL EVALUATION OF SUBCUTANEOUS PERTUZUMAB/TRASTUZUMABVERSUS INTRAVENOUS PERTUZUMAB/TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER IN DENMARK (HEREAFTER)
Mar 18, 2026, 21:38 PM -
ENHANCING CLINICAL TRIAL ELIGIBILITY CRITERIA DESIGN WITH GENERATIVE ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
Mar 18, 2026, 21:38 PM
